Glaucoma Research Today is a free monthly online journal that collates and summarizes the latest research about Glaucoma, including details on cataracts, surgery, treatment, blindness.

Volume 5 (2009), Issue 7 (July)

1. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
   Neuroscience, 162(2): 375-82. [Abstract] [Full-text]
2. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
   Ophthalmology, 116(7): 1237-42. [Abstract] [Full-text]
3. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
   Ophthalmology, 116(7): 1250-6. [Abstract] [Full-text]
4. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study.
   Ophthalmology, 116(7): 1257-63, 1263.e1-2. [Abstract] [Full-text]
5. Meta-analysis of medical intervention for normal tension glaucoma.
   Ophthalmology, 116(7): 1243-9. [Abstract] [Full-text]
6. Comparison of retinal nerve fiber layer thickness measured by Cirrus HD and Stratus optical coherence tomography.
   Ophthalmology, 116(7): 1264-70, 1270.e1. [Abstract] [Full-text]
7. Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherent tomography.
   Ophthalmology, 116(7): 1271-7. [Abstract] [Full-text]
8. Heparan sulfate deficiency leads to Peters anomaly in mice by disturbing neural crest TGF-beta2 signaling.
   J Clin Invest, 119(7): 1997-2008. [Abstract] [Full-text]
9. Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.
   Graefes Arch Clin Exp Ophthalmol, 247(8): 1103-9. [Abstract] [Full-text]
10. Optic nerve head topography in nonglaucomatous, normotensive patients with unilateral exfoliation syndrome.
    Graefes Arch Clin Exp Ophthalmol, 247(8): 1111-7. [Abstract] [Full-text]
11. Restricted post-trabeculectomy bleb formation by conjunctival scarring.
    Graefes Arch Clin Exp Ophthalmol, 247(8): 1095-101. [Abstract] [Full-text]
12. Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.
    Expert Opin Pharmacother, 10(11): 1705-11. [Abstract] [Full-text]
13. Efficacy and safety of a steel drainage device implanted under a scleral flap.
    Can J Ophthalmol, 44(4): 457-62. [Abstract] [Full-text]
14. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Can J Ophthalmol, 44(4): 451-6. [Abstract] [Full-text]
15. Relationship of incident glaucoma versus physical activity and fitness in male runners.
    Med Sci Sports Exerc, 41(8): 1566-72. [Abstract] [Full-text]
16. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Curr Med Res Opin, 25(8): 1879-88. [Abstract] [Full-text]
17. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
    Drug Metab Dispos, 37(8): 1622-34. [Abstract] [Full-text]
18. Neuroprotection: extrapolating from neurologic diseases to the eye.
    Am J Ophthalmol, 148(2): 186-191.e2. [Abstract] [Full-text]
19. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
    Am J Ophthalmol, 148(2): 221-6. [Abstract] [Full-text]
20. Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma.
    Exp Brain Res, 197(2): 101-9. [Abstract] [Full-text]
21. Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeys.
    Exp Eye Res, 89(2): 246-55. [Abstract] [Full-text]
22. CYP1B1, a developmental gene with a potential role in glaucoma therapy.
    Xenobiotica, 39(8): 606-15. [Abstract] [Full-text]
23. Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
    Cornea, 28(7): 759-64. [Abstract] [Full-text]
24. Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma.
    Exp Biol Med (Maywood), 234(8): 918-30. [Abstract] [Full-text]
25. Advances in telemetric continuous intraocular pressure assessment.
    Br J Ophthalmol, 93(8): 992-6. [Abstract] [Full-text]
26. Concordance of flicker comparison versus side-by-side comparison in glaucoma.
    Optometry, 80(8): 437-41. [Abstract] [Full-text]
27. Open-angle glaucoma and the risk of stroke development: a 5-year population-based follow-up study.
    Stroke, 40(8): 2685-90. [Abstract] [Full-text]
28. Intracellular flow in optic nerve axons: a mechanism for cell death in glaucoma.
    Invest Ophthalmol Vis Sci, 50(8): 3750-8. [Abstract] [Full-text]
29. Correction of the disease phenotype of myocilin-causing glaucoma by a natural osmolyte.
    Invest Ophthalmol Vis Sci, 50(8): 3743-9. [Abstract] [Full-text]

© 2005-2013 Glaucoma Research Today. All Rights Reserved.